MCS-3_Endofin_LgBiT
(Plasmid
#182574)
-
PurposeThis plasmid can be used to monitor receptor internalization in real time living cells using bioluminescence as a readout.
-
Depositing Lab
-
Depositing OrganizationUniversity of Houston
Located in the United States of America -
Sequence Information
Ordering
| Item | Catalog # | Description | Quantity | Price (USD) | |
|---|---|---|---|---|---|
| Plasmid | 182574 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $94 | |
| DNA | 182574-D50 | 50 μg of DNA in Tris buffer | $495 | ||
| DNA | 182574-D100 | 100 μg of DNA in Tris buffer | $585 | ||
Backbone
-
Vector backbonepBiT1.1-C [TK/LgBiT]
-
Backbone manufacturerPromega Corporation
- Total vector size (bp) 4056
-
Vector typeMammalian Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert namezinc finger FYVE-type
-
Alt nameFYVE domain
-
SpeciesH. sapiens (human)
-
Insert Size (bp)207
-
MutationFYVE domain Q739-K806
-
Entrez GeneZFYVE16 (a.k.a. PPP1R69)
- Promoter Herpes simplex virus (HSV)
-
Tag
/ Fusion Protein
- LgBiT (Large BiT) (N terminal on insert)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site BgIII (unknown if destroyed)
- 3′ cloning site EcoRI (unknown if destroyed)
- 5′ sequencing primer caccgagcgaccctgcagcga
- 3′ sequencing primer attgatgagtttggacaaacc
- (Common Sequencing Primers)
Resource Information
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
Addgene NGS results confirmed LgBiT sequence is at the N-term of the insert rather than the C-term as shown in the depositor's sequence under Supplemental Documents. The depositor has confirmed that the N-term LgBiT version is the version used in the associated publication.
DNA (Catalog # 182574-D50)
Purpose
Ready-to-use, high-purity DNA prep. DNA aliquots are suitable for use in mammalian cell transfections and other molecular biology applications.
Delivery
- Amount 50 μg
- Concentration 1 μg/μL
- Pricing $495 USD
- Storage 4 ℃ (short-term) or -20 ℃ (long-term)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Quality Control
Every DNA prep is verified by next-generation sequencing, confirming plasmid identity, sequence integrity, and absence of DNA contaminants. Concentration is confirmed to be within ±2.5% of the stated concentration.
Our production process has been validated to consistently yield endotoxin levels below 1.0 EU/μg. Individual lots are not tested for endotoxin.
DNA (Catalog # 182574-D100)
Purpose
Ready-to-use, high-purity DNA prep. DNA aliquots are suitable for use in mammalian cell transfections and other molecular biology applications.
Delivery
- Amount 100 μg
- Concentration 1 μg/μL
- Pricing $585 USD
- Storage 4 ℃ (short-term) or -20 ℃ (long-term)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Quality Control
Every DNA prep is verified by next-generation sequencing, confirming plasmid identity, sequence integrity, and absence of DNA contaminants. Concentration is confirmed to be within ±2.5% of the stated concentration.
Our production process has been validated to consistently yield endotoxin levels below 1.0 EU/μg. Individual lots are not tested for endotoxin.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
MCS-3_Endofin_LgBiT was a gift from Bradley McConnell (Addgene plasmid # 182574 ; http://n2t.net/addgene:182574 ; RRID:Addgene_182574) -
For your References section:
A NanoBiT assay to monitor membrane proteins trafficking for drug discovery and drug development. Reyes-Alcaraz A, Lucero Garcia-Rojas EY, Merlinsky EA, Seong JY, Bond RA, McConnell BK. Commun Biol. 2022 Mar 8;5(1):212. doi: 10.1038/s42003-022-03163-9. 10.1038/s42003-022-03163-9 PubMed 35260793